Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T Cells

  1. Emilie Battivelli
  2. Matthew S Dahabieh
  3. Mohamed Abdel-Mohsen
  4. J Peter Svensson
  5. Israel Tojal Da Silva
  6. Lillian B Cohn
  7. Andrea Gramatica
  8. Steven Deeks
  9. Warner C Greene
  10. Satish K Pillai
  11. Eric Verdin  Is a corresponding author
  1. Gladstone Institutes, United States
  2. University of California, San Francisco, United States
  3. Karolinska Institutet, Sweden
  4. The Rockefeller University, United States

Abstract

Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of latently infected cells. The 'shock and kill' approach to a cure proposes to eliminate this reservoir via transcriptional activation of latent proviruses, enabling direct or indirect killing of infected cells. Currently available latency-reversing agents (LRAs) have however proven ineffective. To understand why, we used a novel HIV reporter strain in primary CD4+ T cells and determined which latently infected cells are reactivatable by current candidate LRAs. Remarkably, none of these agents reactivated more than 5% of cells carrying a latent provirus. Sequencing analysis of reactivatable vs.non-reactivatable populations revealed that the integration sites were distinguishable in terms of chromatin functional states. Our findings challenge the feasibility of 'shock and kill', and suggest the need to explore other strategies to control the latent HIV reservoir.

Data availability

All sequencing data generated during this study are included in the Integration sites Source data file 1

Article and author information

Author details

  1. Emilie Battivelli

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Matthew S Dahabieh

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Mohamed Abdel-Mohsen

    University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. J Peter Svensson

    Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5863-6250
  5. Israel Tojal Da Silva

    Laboratory of Molecular Immunology, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Lillian B Cohn

    Laboratory of Molecular Immunology, The Rockefeller University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3485-8692
  7. Andrea Gramatica

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Steven Deeks

    University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6371-747X
  9. Warner C Greene

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Satish K Pillai

    University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Eric Verdin

    Gladstone Institute of Virology and Immunology, Gladstone Institutes, San Francisco, United States
    For correspondence
    EVerdin@buckinstitute.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3703-3183

Funding

Center for AIDS Research, University of California, San Francisco and Gladstone Institute of Virology and Immunology

  • Emilie Battivelli
  • Mohamed Abdel-Mohsen

National Institute of Dental and Craniofacial Research (5-31532)

  • Eric Verdin

California HIV/AIDS Research Program

  • Emilie Battivelli

Canadian Institutes of Health Research (201311MFE-321128-179658)

  • Matthew S Dahabieh

Svenska Forskningsrådet Formas (VR2015-02312)

  • J Peter Svensson

National Institute of Allergy and Infectious Diseases (R01Ai117864)

  • Eric Verdin

National Institute on Drug Abuse (1R01DA041742-01)

  • Eric Verdin

National Institute of Dental and Craniofacial Research (1R01DE026010-01)

  • Eric Verdin

National Institute of Allergy and Infectious Diseases (R21AI129636)

  • Mohamed Abdel-Mohsen

Cancerfonden (CAN2016/576)

  • J Peter Svensson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2018, Battivelli et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emilie Battivelli
  2. Matthew S Dahabieh
  3. Mohamed Abdel-Mohsen
  4. J Peter Svensson
  5. Israel Tojal Da Silva
  6. Lillian B Cohn
  7. Andrea Gramatica
  8. Steven Deeks
  9. Warner C Greene
  10. Satish K Pillai
  11. Eric Verdin
(2018)
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T Cells
eLife 7:e34655.
https://doi.org/10.7554/eLife.34655

Share this article

https://doi.org/10.7554/eLife.34655

Further reading

    1. Microbiology and Infectious Disease
    Tao Tang, Weiming Zhong ... Zhipeng Gao
    Research Article

    Saprolegnia parasitica is one of the most virulent oomycete species in freshwater aquatic environments, causing severe saprolegniasis and leading to significant economic losses in the aquaculture industry. Thus far, the prevention and control of saprolegniasis face a shortage of medications. Linalool, a natural antibiotic alternative found in various essential oils, exhibits promising antimicrobial activity against a wide range of pathogens. In this study, the specific role of linalool in protecting S. parasitica infection at both in vitro and in vivo levels was investigated. Linalool showed multifaceted anti-oomycetes potential by both of antimicrobial efficacy and immunomodulatory efficacy. For in vitro test, linalool exhibited strong anti-oomycetes activity and mode of action included: (1) Linalool disrupted the cell membrane of the mycelium, causing the intracellular components leak out; (2) Linalool prohibited ribosome function, thereby inhibiting protein synthesis and ultimately affecting mycelium growth. Surprisingly, meanwhile we found the potential immune protective mechanism of linalool in the in vivo test: (1) Linalool enhanced the complement and coagulation system which in turn activated host immune defense and lysate S. parasitica cells; (2) Linalool promoted wound healing, tissue repair, and phagocytosis to cope with S. parasitica infection; (3) Linalool positively modulated the immune response by increasing the abundance of beneficial Actinobacteriota; (4) Linalool stimulated the production of inflammatory cytokines and chemokines to lyse S. parasitica cells. In all, our findings showed that linalool possessed multifaceted anti-oomycetes potential which would be a promising natural antibiotic alternative to cope with S. parasitica infection in the aquaculture industry.

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Iti Mehta, Jacob B Hogins ... Larry Reitzer
    Research Article

    Polyamines are biologically ubiquitous cations that bind to nucleic acids, ribosomes, and phospholipids and, thereby, modulate numerous processes, including surface motility in Escherichia coli. We characterized the metabolic pathways that contribute to polyamine-dependent control of surface motility in the commonly used strain W3110 and the transcriptome of a mutant lacking a putrescine synthetic pathway that was required for surface motility. Genetic analysis showed that surface motility required type 1 pili, the simultaneous presence of two independent putrescine anabolic pathways, and modulation by putrescine transport and catabolism. An immunological assay for FimA—the major pili subunit, reverse transcription quantitative PCR of fimA, and transmission electron microscopy confirmed that pili synthesis required putrescine. Comparative RNAseq analysis of a wild type and ΔspeB mutant which exhibits impaired pili synthesis showed that the latter had fewer transcripts for pili structural genes and for fimB which codes for the phase variation recombinase that orients the fim operon promoter in the ON phase, although loss of speB did not affect the promoter orientation. Results from the RNAseq analysis also suggested (a) changes in transcripts for several transcription factor genes that affect fim operon expression, (b) compensatory mechanisms for low putrescine which implies a putrescine homeostatic network, and (c) decreased transcripts of genes for oxidative energy metabolism and iron transport which a previous genetic analysis suggests may be sufficient to account for the pili defect in putrescine synthesis mutants. We conclude that pili synthesis requires putrescine and putrescine concentration is controlled by a complex homeostatic network that includes the genes of oxidative energy metabolism.